Drug intelligence / Profile preview

potassium magnesium aspartate

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous, Oral
01

Overview

Potassium magnesium aspartate is an electrolyte supplement and cardioprotective agent containing a mixture of potassium and magnesium salts of aspartic acid. Aspartate acts as an active transport carrier with a high affinity for cells, facilitating the entry of potassium and magnesium ions into the intracellular space. This combination helps restore intracellular electrolyte balance, stabilize myocardial electrophysiology, and support cellular energy metabolism. It is clinically approved for the treatment of hypokalemia, digitalis-induced arrhythmias, congestive heart failure, and myocardial infarction, as well as an adjuvant therapy for liver disorders such as hepatitis, liver cirrhosis, and hepatic encephalopathy.

Brand names
AspacardinAsparaAsparkamPananginSpartaseTromcardinWeioulu
Other names
DL-potassium magnesium aspartateK-Mg aspartateL-asparkammagnesium potassium aspartatepotassium aspartate and magnesium aspartatepotassium magnesium aspartate门冬氨酸钾镁
02

Targets

ATP1A (Sodium/potassium-transporting ATPase)

Beyond the preview

Go deeper on potassium magnesium aspartate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on potassium magnesium aspartate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call